574 results on '"Christians, Kathleen"'
Search Results
2. Median arcuate ligament release at the time of pancreaticoduodenectomy or total pancreatectomy
3. Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma
4. CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer
5. Patterns of Unnecessary Insurer Prior Authorization Denials in a Complex Surgical Oncology Practice
6. Biliary Adverse Events During Neoadjuvant Therapy for Pancreatic Cancer
7. Palliative Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis: Is It Safe and Effective?
8. Pancreatic ductal adenocarcinomas associated with intraductal papillary mucinous neoplasms (IPMNs) versus pseudo-IPMNs: relative frequency, clinicopathologic characteristics and differential diagnosis
9. Pancreaticoduodenectomy and Vascular Reconstruction: Indications and Techniques
10. ASO Visual Abstract: CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/ nab-Paclitaxel for Patients with Operable Pancreatic Cancer
11. Adjuvant therapy rates and overall survival in patients with localized pancreatic cancer from high Area Deprivation Index neighborhoods
12. Updates and new directions in the use of radiation therapy for the treatment of pancreatic adenocarcinoma: dose, sensitization, and novel technology
13. Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer
14. Variant anatomy of the biliary system as a cause of pancreatic and peri-ampullary cancers
15. Intraductal papillary squamous neoplasm of the pancreas: Cyto-histologic correlation of a novel entity
16. High neutrophil-lymphocyte ratio is not independently associated with worse survival or recurrence in patients with extremity soft tissue sarcoma
17. Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer
18. Gross tumor size using the AJCC 8th ed. T staging criteria does not provide prognostic stratification for neoadjuvant treated pancreatic ductal adenocarcinoma
19. Role of Molecular Profiling of Pancreatic Cancer After Neoadjuvant Therapy: Does it Change Practice?
20. Total Neoadjuvant Therapy for Operable Pancreatic Cancer
21. Two-Stage Hepatectomy for Bilateral Colorectal Liver Metastases: A Multi-institutional Analysis
22. Primary Liver Cancer: An NCDB Analysis of Overall Survival and Margins After Hepatectomy
23. New Classification of Locally Advanced Pancreatic Cancer
24. Treatment Sequencing for Locally Advanced Pancreatic Cancer
25. Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery
26. RAS Mutation Status Confers Prognostic Relevance in Patients Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer
27. Effect of Donor Race-Matching on Overall Survival for African-American Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma
28. Distal splenorenal and mesocaval shunting at the time of pancreatectomy
29. Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series.
30. Outcomes of Elderly Patients Undergoing Curative Resection for Retroperitoneal Sarcomas: Analysis From the US Sarcoma Collaborative
31. Characterization of an oligometastatic state in patients with metastatic pancreatic adenocarcinoma undergoing systemic chemotherapy
32. Resection Versus Chemotherapy for Metastatic Neuroendocrine Tumors of the Pancreas
33. The effect of prior upper abdominal surgery on outcomes after liver transplantation for hepatocellular carcinoma: An analysis of the database of the organ procurement transplant network
34. Locally advanced pancreas cancer: Staging and goals of therapy
35. Overall survival after resection of retroperitoneal sarcoma at academic cancer centers versus community cancer centers: An analysis of the National Cancer Data Base
36. Management of Acute Cholecystitis during Neoadjuvant Therapy in Patients with Pancreatic Adenocarcinoma
37. Pancreaticoduodenectomy for Neuroendocrine Tumors
38. Cavernous Transformation of the Portal Vein Requiring Temporary Mesocaval Shunt and Internal Jugular Vein Interposition Graft
39. Should functional renal scans be obtained prior to upper abdominal IMRT for pancreatic cancer?
40. Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy?
41. Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis
42. Retroperitoneal lymphangioleiomyoma with lymph node involvement: A pathologic-radiologic correlation of a rare form of myomelanocytic tumor
43. Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer
44. Resection for Neoplasms of the Pancreas
45. Pancreas Adenocarcinoma and Ampullary Cancer
46. Neuroendocrine Tumors of the Pancreas
47. Venous Shunting Procedures for Borderline Resectable Pancreatic Cancer
48. Elective Regional Therapy Treatment for Hepatic Adenoma
49. Characterizing indeterminate liver lesions in patients with localized pancreatic cancer at the time of diagnosis
50. Automated machine learning (AutoML) can predict 90-day mortality after gastrectomy for cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.